Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 114, pseudogene (RNU1-114P), is a human genomic locus classified as a pseudogene within the U1 small nuclear RNA family. Unlike the canonical U1 snRNA genes (such as RNU1-1 through RNU1-4), which produce snRNA essential for accurate pre-mRNA splicing, RNU1-114P is annotated as a pseudogene and is not known to encode a functional RNA transcript. Pseudogenes in the U1 small nuclear RNA cluster typically arise from segmental duplications or evolutionary processes leading to loss of function; there is no evidence that RNU1-114P produces a stable snRNA or participates in cellular function. It is neither a validated therapeutic target nor associated with any established disease roles or biomarker uses[1][3][4][5].
Not applicable; no known mechanisms due to lack of recognized biological activity or drug interaction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 114, pseudogene (RNU1-114P).